Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Contracts
  • News

GreenLight Biosciences, Germains Seed Technology Partner To Explore Development Of World’s First dsRNA Seed Treatment To Control Pests

By Benzinga Newsdesk
January 31, 11:44 AM
 GreenLight Biosciences and Germains Seed Technology, an industry leader in seed treatment technologies, today announced a research partnership agreement that could lead to the first commercial use of RNA

ENVI

Read More
1 minute read
  • M&A

ENVI Announces Quorum To Pass Business Combination With GreenLight Biosciences And Achievement Of All Transaction Requirements Following The Redemption Deadline

By Bill Haddad
January 28, 10:04 AM
Upon consummation of the business combination, the ENVI ticker will transition to "GRNA" and is expected to start trading on the Nasdaq on February 3, 2022 BOSTON, Jan. 28, 2022 /PRNewswire/ -- Environmental

ENVI

Read More
2 minute read
  • M&A

Environmental Impact Acquisition corp. Files Proxy Statement/Prospectus For Feb 1, 2022 Special Meeting To Approve Proposed Business Combo With GreenLight Bio

By Benzinga Newsdesk
January 14, 11:31 AM
Environmental Impact Acquisition Corporation (NASDAQ:ENVI) ("ENVI"), a publicly-traded special purpose acquisition company, announced today that ENVI's definitive proxy statement/prospectus (the "Proxy

ENVI

Read More
3 minute read
  • Contracts
  • News

Environmental Impact Acquisition’s GreenLight Biosciences Partners With IAVI To Accelerate COVID-19 Vaccine Trial In Africa

By Benzinga Newsdesk
November 30, 11:55 AM
GreenLight Biosciences has partnered with the non-profit scientific research organization IAVI to work together on a Phase I clinical trial in Africa. IAVI and its partners were among the first to conduct HIV

ENVI

Read More
2 minute read
  • News

Environmental Impact Acquisition Corp., GreenLight Biosciences Report Expansion Of Its PIPE Financing To $124M In Gross Proceeds

By Benzinga Newsdesk
November 23, 9:34 AM
GreenLight Biosciences Inc., an RNA-focused biotech ("GreenLight"), and Environmental Impact Acquisition Corp. (NASDAQ:ENVI) today announced an expansion of its PIPE financing to an aggregate $124 million in

ENVI

Read More
3 minute read
  • News

Environmental Impact Acquisition Corp. SPAC Merger Partner Greenlight Bio To Host Science Day To Update Investors On Co.’s Progress Towards Unlocking Potential In RNA

By Benzinga Newsdesk
October 19, 12:00 PM
- 7 agricultural products in development with an addressable market of $6bn that we plan to launch by 2026. - Control of fungal pathogens using double-stranded RNA has been demonstrated in field testing for the first

ENVI

Read More
1 minute read
  • Biotech
  • Financing
  • General
  • Health Care
  • IPOs
  • News
  • Offerings

RNA Tech Vaccine Developer GreenLight Biosciences Riding To NASDAQ Debut Via $1.5B SPAC Deal

By Vandana Singh
August 10, 2:44 PM
GreenLight Biosciences Inc is combining with a special-purpose acquisition company to go public in a deal that values the…

ENVI

Read More
5 minute read
  • M&A

Environmental Impact Acquisition Corp. Reports SPAC Merger With GreenLight Biosciences, Expected Enterprise Value $1.2B

By Benzinga Newsdesk
August 10, 8:05 AM
GreenLight Biosciences, Inc. to become publicly listed through business combination with Environmental Impact Acquisition Corp. (NASDAQ:ENVI) Transaction advances development of breakthrough biomanufacturing platform

ENVI

Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service